Guilong Deng

411 total citations
18 papers, 270 citations indexed

About

Guilong Deng is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Guilong Deng has authored 18 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Guilong Deng's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Selenium in Biological Systems (3 papers). Guilong Deng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Selenium in Biological Systems (3 papers). Guilong Deng collaborates with scholars based in China, Austria and Germany. Guilong Deng's co-authors include Lin Zhong, Jiujiang Zhao, Zhifang Chai, Yuanyuan Li, Guohe Song, Xiaoliang Wang, Xing Sun, Zhaowen Wang, Kai Wang and Yuxi Gao and has published in prestigious journals such as The Science of The Total Environment, Medicine and World Journal of Gastroenterology.

In The Last Decade

Guilong Deng

18 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guilong Deng China 10 95 71 57 54 47 18 270
Atsushi Fukumura Japan 10 78 0.8× 94 1.3× 49 0.9× 18 0.3× 33 0.7× 17 368
Linda Carlsson Sweden 9 83 0.9× 37 0.5× 64 1.1× 24 0.4× 57 1.2× 9 350
Koichiro Miyagawa Japan 10 146 1.5× 44 0.6× 56 1.0× 51 0.9× 9 0.2× 39 334
Shinji Oe Japan 10 147 1.5× 40 0.6× 51 0.9× 71 1.3× 9 0.2× 44 381
Louise Biquard France 4 155 1.6× 23 0.3× 31 0.5× 71 1.3× 27 0.6× 5 657
Kalipatnapu N. Rao United States 12 50 0.5× 32 0.5× 19 0.3× 44 0.8× 23 0.5× 20 331
Ian Huck United States 6 94 1.0× 18 0.3× 15 0.3× 50 0.9× 16 0.3× 10 345
Mutuyosi Koga Japan 11 68 0.7× 108 1.5× 153 2.7× 142 2.6× 14 0.3× 16 452
Yanlan Fang China 6 271 2.9× 19 0.3× 12 0.2× 50 0.9× 159 3.4× 23 390

Countries citing papers authored by Guilong Deng

Since Specialization
Citations

This map shows the geographic impact of Guilong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilong Deng more than expected).

Fields of papers citing papers by Guilong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilong Deng. The network helps show where Guilong Deng may publish in the future.

Co-authorship network of co-authors of Guilong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Guilong Deng. A scholar is included among the top collaborators of Guilong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilong Deng. Guilong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wu, Gang, Chen Qiu, Zhijie Zhou, et al.. (2022). Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments. World Journal of Gastroenterology. 28(25). 2937–2954. 9 indexed citations
2.
Zhu, Xian, et al.. (2022). HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters. International Journal of Genomics. 2022. 1–12. 7 indexed citations
3.
4.
Shen, Weixing, Gang Wu, Changjiang Qin, et al.. (2021). The role of SAMM50 in non‐alcoholic fatty liver disease: from genetics to mechanisms. FEBS Open Bio. 11(7). 1893–1906. 16 indexed citations
5.
Xiao, Jingbo, Junyong Weng, Yangyang Hu, Guilong Deng, & Xinjian Wan. (2020). Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma. World Journal of Gastroenterology. 26(31). 4589–4606. 14 indexed citations
6.
Wang, Xiaoliang, Zhipeng Liu, Kai Wang, et al.. (2016). Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population. Frontiers in Genetics. 7. 140–140. 54 indexed citations
8.
Sheng, Tao, Bin Wang, Shuyun Wang, et al.. (2015). The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection. Medicine. 94(24). e941–e941. 26 indexed citations
9.
Chen, Chunying, Liya Qu, Jiujiang Zhao, et al.. (2006). Accumulation of mercury, selenium and their binding proteins in porcine kidney and liver from mercury-exposed areas with the investigation of their redox responses. The Science of The Total Environment. 366(2-3). 627–637. 35 indexed citations
10.
Yu, Hongwei, Chunying Chen, Jiangxue Wang, et al.. (2006). Preliminary study of oxidative stress in human hepatocellular carcinoma and adjacent normal liver tissues. Chinese Journal of Clinical Oncology. 3(1). 11–14. 2 indexed citations
11.
Deng, Guilong, Chunying Chen, Peiqun Zhang, et al.. (2005). Studies on cellular distribution of elements in human hepatocellular carcinoma samples by molecular activation analysis. Nuclear Techniques. 28. 2 indexed citations
12.
Feng, Weiyue, Meng Wang, Yuanyuan Li, et al.. (2004). Mercury and trace element distribution in organic tissues and regional brain of fetal rat after in utero and weaning exposure to low dose of inorganic mercury. Toxicology Letters. 152(3). 223–234. 30 indexed citations
13.
Gao, Yuxi, et al.. (2004). Distribution of Selenium-Containing Proteins in Human Serum. Biological Trace Element Research. 100(2). 105–116. 20 indexed citations
14.
Peng, Shu-you, Yingbin Liu, Xiu-jun Cai, et al.. (2004). [Role and significance of extrahepatic control of hepatic vein and inferior vena cava in difficult hepatectomies for patients with liver tumors].. PubMed. 42(5). 260–4. 6 indexed citations
15.
Chen, Chunying, Guilong Deng, Jiujiang Zhao, et al.. (2004). [Preliminary study on cellular status of selenium and oxidative stress in human hepatocellular carcinoma and normal liver].. PubMed. 33(5). 543–6. 2 indexed citations
16.
Liu, Yingbin, Jianwei Wang, Chenghong Peng, et al.. (2004). [Effect of binding pancreaticojejunotomy in prevention of post-operational anastomotic leakage: a clinical study of 200 cases].. PubMed. 84(12). 997–9. 4 indexed citations
17.
Peng, Shu-you, et al.. (2004). Hepatocellular carcinoma with bile duct thrombi: analysis of surgical treatment.. PubMed. 51(57). 801–4. 8 indexed citations
18.
Chen, Xiaopeng, Shu-you Peng, Yulian Wu, et al.. (2002). [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].. PubMed. 82(22). 1553–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026